151 related articles for article (PubMed ID: 30904385)
21. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
22. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
23. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
[TBL] [Abstract][Full Text] [Related]
24. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
25. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).
Wada T; Kang HS; Angers M; Gong H; Bhatia S; Khadem S; Ren S; Ellis E; Strom SC; Jetten AM; Xie W
Mol Pharmacol; 2008 Mar; 73(3):891-9. PubMed ID: 18055760
[TBL] [Abstract][Full Text] [Related]
26. RORα autoregulates its transcription via MLL4-associated enhancer remodeling in the liver.
Han YH; Kim HJ; Choi H; Lee S; Lee MO
Life Sci; 2020 Sep; 256():118007. PubMed ID: 32598934
[TBL] [Abstract][Full Text] [Related]
27. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity.
Lopez-Pastor AR; Gomez-Hernandez A; Diaz-Castroverde S; Gonzalez-Aseguinolaza G; Gonzalez-Rodriguez A; Garcia G; Fernandez S; Escribano O; Benito M
Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30642871
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
[TBL] [Abstract][Full Text] [Related]
29. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
30. RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.
Kim HJ; Han YH; Kim JY; Lee MO
Hepatol Commun; 2021 Dec; 5(12):2121-2138. PubMed ID: 34558854
[TBL] [Abstract][Full Text] [Related]
31. Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.
Kim YJ; Choi JY; Ryu R; Lee J; Cho SJ; Kwon EY; Lee MK; Liu KH; Rina Y; Sung MK; Choi MS
Nutrients; 2016 Aug; 8(9):. PubMed ID: 27589792
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice.
Chartoumpekis DV; Palliyaguru DL; Wakabayashi N; Fazzari M; Khoo NKH; Schopfer FJ; Sipula I; Yagishita Y; Michalopoulos GK; O'Doherty RM; Kensler TW
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E180-E195. PubMed ID: 29486138
[TBL] [Abstract][Full Text] [Related]
33. Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.
Saunders BM; Rudnicka C; Filipovska A; Davies S; Ward N; Hricova J; Schlaich MP; Matthews VB
Immunol Cell Biol; 2018 Jan; 96(1):41-53. PubMed ID: 29359470
[TBL] [Abstract][Full Text] [Related]
34. The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.
Ceddia RP; Lee D; Maulis MF; Carboneau BA; Threadgill DW; Poffenberger G; Milne G; Boyd KL; Powers AC; McGuinness OP; Gannon M; Breyer RM
Endocrinology; 2016 Jan; 157(1):220-32. PubMed ID: 26485614
[TBL] [Abstract][Full Text] [Related]
35. Restricted feeding for 9h in the active period partially abrogates the detrimental metabolic effects of a Western diet with liquid sugar consumption in mice.
Woodie LN; Luo Y; Wayne MJ; Graff EC; Ahmed B; O'Neill AM; Greene MW
Metabolism; 2018 May; 82():1-13. PubMed ID: 29253490
[TBL] [Abstract][Full Text] [Related]
36. Fat-enriched rather than high-fructose diets promote whitening of adipose tissue in a sex-dependent manner.
Dobner J; Ress C; Rufinatscha K; Salzmann K; Salvenmoser W; Folie S; Wieser V; Moser P; Weiss G; Goebel G; Tilg H; Kaser S
J Nutr Biochem; 2017 Nov; 49():22-29. PubMed ID: 28863366
[TBL] [Abstract][Full Text] [Related]
37. Depot-Specific Response of Adipose Tissue to Diet-Induced Inflammation: The Retinoid-Related Orphan Receptor α (RORα) Involved?
Kadiri S; Auclair M; Capeau J; Antoine B
Obesity (Silver Spring); 2017 Nov; 25(11):1948-1955. PubMed ID: 28941206
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
39. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
40. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
